Vaping-related lung injury.
Maxwell L SmithMichael B GotwayLaura E Crotty AlexanderLida P HaririPublished in: Virchows Archiv : an international journal of pathology (2020)
The use of electronic nicotine delivery systems has increased in popularity dramatically over the past decade. Although lung diseases caused by vaping have been reported since the modern invention of the electronic cigarette, in the summer of 2019, patients began to present to health care centers at epidemic levels with an acute respiratory illness relating to vaping, which the Center for Disease Control termed E-cigarette or vaping product use-associated lung injury (EVALI). This review discusses electronic nicotine delivery systems as well as the etiology, clinical presentation, imaging findings, pathologic features, treatment, and long-term consequences of EVALI. We conclude with the practical impact EVALI has had on the practice of pathology.
Keyphrases
- smoking cessation
- healthcare
- end stage renal disease
- ejection fraction
- newly diagnosed
- primary care
- chronic kidney disease
- liver failure
- replacement therapy
- peritoneal dialysis
- neoadjuvant chemotherapy
- prognostic factors
- patient reported outcomes
- radiation therapy
- lymph node
- respiratory failure
- hepatitis b virus
- intensive care unit
- locally advanced
- health information